(9Z)-UAB-30

N/A

Report date: 2024/05/23 20:00:04
NME

Base Information

Drug Name(9Z)-UAB-30
Drug Alias Namecis-UAB-309-cis-UAB-30UAB-309c-UAB-30
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor alpha agonists
TargetsRetinoid X receptor alpha
Therapy Area/IndicationsSkin NeoplasmsBreast NeoplasmsCarcinoma, Ductal, Breast
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteUniversity Of Alabama At Birmingham
Active IndicationsN/A
Inactive IndicationsSkin NeoplasmsBreast NeoplasmsCarcinoma, Ductal, Breast

Other Information

ATC CodeN/A
Related LinksN/A